Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6300-6303, November 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobson, E. A.
Right arrow Articles by Carroll, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobson, E. A.
Right arrow Articles by Carroll, K. K.

Effects of Dietary Fat, Calcium, and Vitamin D on Growth and Mammary Tumorigenesis Induced by 7,12-Dimethylbenz(a)anthracene in Female Sprague-Dawley Rats1

E. Ann Jacobson, Kathi A. James, Harold L. Newmark and Kenneth K. Carroll2

Department of Biochemistry, University of Western Ontario, London, Ontario, N6A 5C1 Canada [E. A. J., K. A. J., K. K. C.], and Laboratory of Gastrointestinal Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

This study was designed to test the influence of dietary calcium and vitamin D levels on the promotional effect of high-fat diets on chemically induced mammary carcinogenesis. In a small preliminary experiment (Experiment A), 40 female Sprague-Dawley rats, 43 days old, were randomly divided into 5 groups (8 rats/group) and fed a semipurified diet containing 3% sunflower seed oil (SF) by weight, 1.5 mg of calcium/kcal and 0.5 IU vitamin D/kcal of diet. After 1 week, each rat was given 2.5 mg of dimethylbenz(a)anthracene by gastric gavage. One week later, the animals were switched to 1 of 4 diets varying in fat (3 or 20% SF by weight), calcium (1.5 or 0.25 mg/kcal), vitamin D (0.5 or 0.05 IU/kcal), and phosphate or to a fifth diet containing 3% SF by weight, 0.1 mg of calcium/kcal and 0.05 IU of vitamin D/kcal. In all 5 diets, calcium:phosphate weight ratios were maintained at 1.2:1. In animals fed the high-fat diet, reduction of dietary calcium (1.5 to 0.25 mg/kcal) and vitamin D (0.5 to 0.05 IU/kcal) increased the incidence of mammary lesions from 37 to 75% and the total number of lesions from 4 to 16. A trend toward an increase in lesion weight and total lesion burden was also seen.

To confirm these results, the experiment was repeated using the same protocol; 126 rats were divided into 6 groups, treated with dimethylbenz(a)anthracene, and fed the diets as described. A sixth diet was included that contained 20% SF by weight, 0.01 mg of calcium/kcal, and 0.05 IU of vitamin D/kcal. As for Experiment A, in animals fed the high-fat diet, reduction of dietary calcium (1.5 to 0.25 mg/kcal) and vitamin D (0.5 to 0.05 IU/kcal) resulted in an increase in total mammary lesions from 31 to 55, a significant increase in average lesion burden/rat with lesions (1.6 ± 0.6 to 12 ± 3 g), and a trend toward increasing weight of lesions. The effect was less obvious in animals fed the low-fat diet where, in both experiments, an increase in the incidence of mammary lesions was observed only when the dietary calcium was reduced from 1.5 to 0.1 mg/kcal. These data suggest that decreasing calcium and vitamin D increase the promoting effects of a high-fat diet on mammary tumorigenesis in the rat.

1 This work was supported by the Dairy Bureau of Canada through the cooperation of Dr. M. A. (Vic) Amer, Senior Vice-President, Science and Technology.

2 Career Investigator of the Medical Research Council of Canada.

Received 5/24/88. Revised 12/27/88. Revised 8/16/89. Accepted 8/22/89.




This article has been cited by other articles:


Home page
J. Nutr.Home page
T. M. Chlon, D. A. Taffany, J. Welsh, and M. J. Rowling
Retinoids Modulate Expression of the Endocytic Partners Megalin, Cubilin, and Disabled-2 and Uptake of Vitamin D-Binding Protein in Human Mammary Cells
J. Nutr., July 1, 2008; 138(7): 1323 - 1328.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. C. Fleet, C. Gliniak, Z. Zhang, Y. Xue, K. B. Smith, R. McCreedy, and S. A. Adedokun
Serum Metabolite Profiles and Target Tissue Gene Expression Define the Effect of Cholecalciferol Intake on Calcium Metabolism in Rats and Mice
J. Nutr., June 1, 2008; 138(6): 1114 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Lin, J. E. Manson, I-M. Lee, N. R. Cook, J. E. Buring, and S. M. Zhang
Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women
Arch Intern Med, May 28, 2007; 167(10): 1050 - 1059.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C Palmieri, T MacGregor, S Girgis, and D Vigushin
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer
J. Clin. Pathol., December 1, 2006; 59(12): 1334 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Cui and T. E. Rohan
Vitamin d, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Kemmis, S. M. Salvador, K. M. Smith, and J. Welsh
Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3
J. Nutr., April 1, 2006; 136(4): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. McCullough, C. Rodriguez, W. R. Diver, H. S. Feigelson, V. L. Stevens, M. J. Thun, and E. E. Calle
Dairy, Calcium, and Vitamin D Intake and Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II Nutrition Cohort
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2898 - 2904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Welsh
Vitamin D and breast cancer: insights from animal models
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1721S - 1724S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. M. Zinser and J. Welsh
Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice
Carcinogenesis, December 1, 2004; 25(12): 2361 - 2372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. G Moorman and P. D Terry
Consumption of dairy products and the risk of breast cancer: a review of the literature
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 5 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez
Vitamin D-3 Receptor as a Target for Breast Cancer Prevention
J. Nutr., July 1, 2003; 133(7): 2425S - 2433.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-H. Shin, M. D. Holmes, S. E. Hankinson, K. Wu, G. A. Colditz, and W. C. Willett
Intake of Dairy Products, Calcium, and Vitamin D and Risk of Breast Cancer
J Natl Cancer Inst, September 4, 2002; 94(17): 1301 - 1310.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. Newmark, K. M. Wittkowski, S. J. Shiff, J. Hirsch, M. D. Holmes, B. Rosner, and W. C. Willett
Dietary Fat and Risk of Breast Cancer
JAMA, October 6, 1999; 282(13): 1223 - 1224.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. Lipkin and H. L. Newmark
Vitamin D, Calcium and Prevention of Breast Cancer: A Review
J. Am. Coll. Nutr., October 1, 1999; 18(90005): 392S - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R.-K. He and M. Gascon-Barré
Influence of the Vitamin D Status on the Early Hepatic Response to Carcinogen Exposure in Rats
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 464 - 469.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.